Stock Price
89.36
Daily Change
0.61%
Yearly
2.67%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Alcon AG 71.18 -0.18 -0.25% 9.17%
Almirall SA 10.82 0.09 0.84% -9.46%
Amarin 3.36 -0.16 -4.55% -46.58%
argenx SE 247.90 -2.90 -1.16% 3.46%
Artemis Alpha 420.00 -3.00 -0.71% 5.53%
AstraZeneca 8,726.00 -1.00 -0.01% 14.14%
Bayer 51.60 -0.46 -0.88% -3.91%
Genmab 2,238.00 -54.00 -2.36% -17.42%
Galapagos 47.69 -0.66 -1.37% -46.68%
GRIFOLS 17.15 0.23 1.36% -32.42%
GlaxoSmithKline 1,672.71 -28.49 -1.68% 21.23%
Hikma Pharmaceutical 2,020.48 -8.52 -0.42% -20.42%
Lonza Group 641.60 -5.40 -0.83% 8.12%
H Lundbeck A/S 161.30 -0.40 -0.25% -29.53%
Merck 187.60 -2.40 -1.26% 31.46%
Novartis 81.71 -0.39 -0.48% -5.00%
Orion 35.95 0.12 0.33% -7.25%
Recordati 50.16 -2.06 -3.94% 17.88%
Roche Holding 364.50 -0.40 -0.11% 13.91%
Sanofi 91.51 -0.55 -0.60% 11.12%
UCB 89.36 0.54 0.61% 2.67%
Unibail Rodamco 66.20 0.17 0.26% 9.28%

Indexes Price Day Year
BE20 4208 -11.60 -0.27% 12.31%
EU100 1354 6.59 0.49% 19.78%

UCB
Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.